Pirfenidone: A novel hypothetical treatment for COVID-19

Cytokine storm, multiorgan failure, and particularly acute respiratory distress syndrome (ARDS) is the leading cause of mortality and morbidity in patients with COVID-19. A fulminant ARDS kills the majority of COVID-19 victims. Pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), is a novel anti-fibroti...

Descripción completa

Detalles Bibliográficos
Autor principal: Seifirad, Soroush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297676/
https://www.ncbi.nlm.nih.gov/pubmed/32575019
http://dx.doi.org/10.1016/j.mehy.2020.110005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297676/
https://www.ncbi.nlm.nih.gov/pubmed/32575019
http://dx.doi.org/10.1016/j.mehy.2020.110005

Ejemplares similares